Table 1.
Univariable and multivariable logistic regression models evaluating the relationship between patient characteristics and the development of complicated COVID-19 disease
| Characteristic | Univariable OR | 95% CI | P value | Multivariable OR | 95% CI | P value | |
|---|---|---|---|---|---|---|---|
| Sex, M/F | 2.41 | 1.80–3.24 | <0.0001 | 2.01 | 1.46–2.77 | <0.0001 | |
| Age, <65/≥65 | 2.44 | 1.81–3.28 | <0.0001 | 1.90 | 1.37–2.65 | <0.0001 | |
| Comorbidities, 0–1/≥2 | 2.47 | 1.83–3.35 | <0.0001 | 1.75 | 1.24–2.46 | 0.001 | |
| Tumor stage, nonadvanced/advanced | 0.84 | 0.62–1.12 | 0.23 | 1.24 | 0.85–1.81 | 0.26 | |
| Tumor status | 0.67 | 0.49–0.92 | 0.012 | 0.69 | 0.46–1.03 | 0.07 | |
| Remission/no measurable disease | |||||||
| Active malignancy | |||||||
| Anticancer therapy, no/yes | 0.52 | 0.39–0.70 | <0.0001 | 0.68 | 0.48–1.00 | P = 0.03 | |
| Immunotherapy ongoing, no/yes | 1.12 | 0.59–2.14 | 0.73 | ||||
| Chemotherapy ongoing, no/yes | 1.15 | 0.78–1.68 | 0.47 | ||||
| Targeted therapy ongoing, no/yes | 0.65 | 0.40–1.05 | 0.08 |